Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 507
Selected: 0
NCT IDTitle
NCT04423965A Trial of Neoadjuvant mFOLFOXIRI Versus CRT in the EMVI Positive LARC
NCT01915134Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal Carcinoma
NCT03031444Perioperative Chemotherapy Plus Cetuximab Versus Chemotherapy Alone for High Risk Resectable Colorectal Liver Metastasis
NCT07074353Irinotecan Liposomes in Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer
NCT03317483DEB-TACE Treatment in 367 Liver Cancer Patients
NCT06200051Multi-cancer Joint Screening and Early Diagnosis and Treatment Project Based on the Combination of Chinese Traditional and Western Medicine in Lanxi City
NCT01688713Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer
NCT03339882Remifemin Preventing the Climacteric Symptoms in Breast Cancer
NCT03615170Application of Circulating Tumor DNA Test in the Diagnosis and Treatment of Patients With Advanced Rectal Cancer
NCT03792542Anlotinib Hydrochloride For Advanced Soft Tissue Sarcoma Patients Who Do Not Receive Chemotherapy
NCT05248022Efficacy and Safety of DEB-BACE Combined With PD-1 Inhibitors in Stage II/III NSCLC With Standard Treatment Failure
NCT05669807Camrelizumab Combined With Irinotecan or Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer
NCT04291092Camrelizumab Combined With Local Treatment in NSCLC Patients With BM
NCT01463501Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer
NCT06610799Study of IBI363 in Patients with Advanced First-line Gastric Cancer
NCT06713421Effect of Premedication With Pronase on Mucosal Cleanliness During EGD
NCT04974346Para-aortic Prophylactic Irradiation for Locally Advanced Cervical Cancer
NCT07330544A Phase II Clinical Study Evaluating Entinostat With or Without Anlotinib + Fulvestrant for the Treatment of Hormone Receptor (HR) -Positive, Human Epidermal Growth Factor Receptor-2 (HER-2) -Negative Advanced Breast Cancer That Relapsed or Progressed After Endocrine Therapy
NCT05896059A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Anlotinib as Maintenance Therapy for ES-SCLC
NCT05466279The Role of Remazolam in Reducing the Incidence of Postoperative Delirium in Elderly Patients
NCT05007587Lenvatinib Plus HAIC of Modified FOLFOX Regime vs Lenvatinib Plus HAIC of ROX Regime in Patients With Advanced HCC
NCT04319601Rituximab Combined With Chidamide and Lenalidomide for r/r AITL
NCT04920214Application Value of CEUS Li-RADS in Hepatic Focal Lesions in Patients With Non-high Risk Factors for HCC
NCT03876587Pyrotinib Combined With Docetaxel in the First-line Treatment of HER2-positive MBC
NCT03116984A Study of Comparison of TACE Combination With and Without EBRT for Advanced HCC
NCT03439904Individualized Pharmaceutical-care in Outpatients With Cancer Pain
NCT02769104Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer
NCT04255836Durvalumab Combined With Chemotherapy and Stereotactic Body Radiotherapy (SBRT) in Patients With Oligometastatic Non-small Cell Lung Cancer (NSCLC)
NCT05322499Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell Cancer
NCT02356276Efficacy of HIPEC in the Treatment of Locally Advanced Gastric Cancer After radIcal Gastrectomy With D2
NCT07035808a Single Arm, Phase II Multicenter Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of Iparomlimab and Tuvonralima b and Chemotherapy ± Bevacizumab Induction Therapy Followed by Concurrent Chemoradiotherapy in Patients With Advanced Cervical Cancer .
NCT02878889A Phase II Trial of S-1 as Maintenance Treatment After Gemcitabine Plus Cisplatin Regimen Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma.
NCT06624878Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer
NCT04249440Preoperative Systemic Therapy vs Upfront Surgery in HER2 Positive Early Breast Cancer
NCT04560751TACE Combined With Lenvatinib for Unresectable Hepatocellular Carcinoma (Prolong)
NCT06378580The Prognostic Impact of Surufatinib for the Treatment of Advanced Pancreatic Ductal Adenocarcinoma
NCT07271823Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer
NCT05550090Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC
NCT07175207Study on Safety and Efficacy of UCB-MNCs for Chronic Radiation Enteritis
NCT04513418Effects of Preoperative Enteral Immunonutrition for Esophageal Cancer Patients Given Neoadjuvant Chemoradiotherapy
NCT06766305QL1706 Combined With SOX Used in Theperioperative Treatment
NCT05054166Efficacy of Everolimus-containing Chemotherapy in HER2- mBC Patients With PI3K/AKT/mTOR Mutations Study
NCT06120426En Bloc Resection Versus Separation Surgery Combined With Radiotherapy for the Treatment of Spinal Oligometastatic Tumor.
NCT06429514Study on the Mechanism of Ganoderma Lucidum Spore Powder in the Treatment of Depression
NCT06711432Different Intraoperative Blood Pressure Management on Postoperative Cognitive Function in Tumor Patients(PRECISION)
NCT05273944Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients
NCT04981665A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection
NCT01635400Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer
NCT02804217Acquired Resistant Mechanism of the First-generation EGFR TKIs
NCT06481956T-DM1 Combined With CDK4/6 Inhibitor Ribociclib